Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3463 Target Snapshot

Human immunodeficiency virus type 2 integrase · SINGLE PROTEIN · Human immunodeficiency virus 2

6Compounds
7Assays
1Approved Drugs
9.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P89582. Use UniProt P89582 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P89582 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Human immunodeficiency virus type 2 integrase as ChEMBL target CHEMBL3463, mapped to UniProt P89582. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Human immunodeficiency virus type 2 integrase
SINGLE PROTEIN · Human immunodeficiency virus 2
As of 2026-09-14
ChEMBL target ID
CHEMBL3463
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P89582
Integrase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Human immunodeficiency virus type 2 integrase is the right protein anchor across sources, using UniProt P89582 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelIntegrase
UniProt AccessionP89582
Component TypeProtein
Sequence Length95 aa

Integrase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Human immunodeficiency virus type 2 integrase, mapped to UniProt P89582. ChEMBL maps the protein component as Integrase. Sequence length is 95 aa.

Mapped IDP89582
Review nameHuman immunodeficiency virus type 2 integrase
OrganismHuman immunodeficiency virus 2
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC508.0
EC501.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1229211 8.64 EC50 2.3 Approved
CHEMBL177126 6.3 IC50 500.0 Preclinical
CHEMBL293914 6.0 IC50 1000.0 Preclinical
CHEMBL175266 5.82 IC50 1500.0 Preclinical
CHEMBL174366 5.8 IC50 1600.0 Preclinical
CHEMBL366356 5.6 IC50 2500.0 Preclinical
Distribution

pChEMBL Value Distribution

0
5.0
5
5.5
3
6.0
0
6.5
0
7.0
0
7.5
0
8.0
1
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

DOLUTEGRAVIR
CHEMBL1229211
Approved 2013
Assay Landscape

Assay Landscape

7
Total Assays
6
Tested Compounds
1
Assay Types
Binding — 7 assays, 6 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 7 6 6.2

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine